. Service-d-'immunologie-clinique, 12 Service d'Hématologie Pédiatrique, Hôpital Robert Debré, 75019 Paris, France. 13 Institut d'Oncologie et Hématologie Pédiatrique, Research on Medication and Innovative Therapeutics (LERMIT), 32 rue des Carnets, p.15, 92140.

Z. Ww, Myelokathexis"?A New Form of Chronic Granulocytopenia Report of a case, N Engl J Med, vol.270, pp.699-704, 1964.

M. Wetzler, M. Talpaz, E. Kleinerman, A. King, Y. Huh et al., A new familial immunodeficiency disorder characterized by severe neutropenia, a defective marrow release mechanism, and hypogammaglobulinemia, The American Journal of Medicine, vol.89, issue.5, pp.663-672, 1990.
DOI : 10.1016/0002-9343(90)90187-I

L. Dotta, L. Tassone, and R. Badolato, Clinical and Genetic Features of Warts, Hypogammaglobulinemia, Infections and Myelokathexis (WHIM) Syndrome, Current Molecular Medicine, vol.11, issue.4, pp.317-325, 2011.
DOI : 10.2174/156652411795677963

P. Hernandez, R. Gorlin, J. Lukens, S. Taniuchi, J. Bohinjec et al., Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease, Nature Genetics, vol.34, issue.1, pp.70-74, 2003.
DOI : 10.1038/ng1149

Q. Liu, H. Chen, T. Ojode, X. Gao, S. Naya-o-'brien et al., WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4, Blood, vol.120, issue.1, pp.181-189, 2012.
DOI : 10.1182/blood-2011-12-395608

F. Bachelerie, CXCL12/CXCR4-Axis Dysfunctions: Markers of the Rare Immunodeficiency Disorder WHIM Syndrome, Disease Markers, vol.29, issue.3-4, pp.189-198, 2010.
DOI : 10.1155/2010/475104

K. Balabanian, B. Lagane, J. Pablos, L. Laurent, T. Planchenault et al., WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12, Blood, vol.105, issue.6, pp.2449-2457, 2005.
DOI : 10.1182/blood-2004-06-2289
URL : https://hal.archives-ouvertes.fr/pasteur-00166808

K. Balabanian, A. Levoye, L. Klemm, B. Lagane, O. Hermine et al., Leukocyte analysis from WHIM syndrome patients reveals a pivotal role for GRK3 in CXCR4 signaling, Journal of Clinical Investigation, vol.118, pp.1074-1084, 2008.
DOI : 10.1172/JCI33187
URL : https://hal.archives-ouvertes.fr/hal-00259431

J. Bohinjec, Myelokathexis: Chronische Neutropenie mit hyperplastischem Knochenmark und hypersegmentierten Neutrophilen bei einem Geschwisterpaar, Blut, vol.270, issue.3, pp.191-196, 1981.
DOI : 10.1007/BF01026389

T. Kawai, U. Choi, L. Cardwell, S. Deravin, N. Naumann et al., WHIM syndrome myelokathexis reproduced in the NOD/SCID mouse xenotransplant model engrafted with healthy human stem cells transduced with C-terminus-truncated CXCR4, Blood, vol.109, issue.1, pp.78-84, 2007.
DOI : 10.1182/blood-2006-05-025296

K. Balabanian, E. Brotin, V. Biajoux, L. Bouchet-delbos, E. Lainey et al., Proper desensitization of CXCR4 is required for lymphocyte development and peripheral compartmentalization in mice, Blood, vol.119, issue.24, pp.5722-5730, 2012.
DOI : 10.1182/blood-2012-01-403378

K. Alapi, M. Erdos, G. Kovacs, and L. Marodi, Recurrent CXCR4 sequence variation in a girl with WHIM syndrome, European Journal of Haematology, vol.90, issue.1, pp.86-88, 2007.
DOI : 10.1124/mol.105.020271

A. Aprikyan, W. Liles, J. Park, J. M. Chi, E. Dale et al., Myelokathexis, a congenital disorder of severe neutropenia characterized by accelerated apoptosis and defective expression of bcl-x in neutrophil precursors, Blood, vol.95, pp.320-327, 2000.

R. Bassan, P. Viero, B. Minetti, B. Comotti, and T. Barbui, Myelokathexis: a rare form of chronic benign granulocytopenia, British Journal of Haematology, vol.270, issue.1, pp.115-117, 1984.
DOI : 10.1111/j.1365-2141.1984.tb06065.x

J. Bohinjec and D. Andoljsek, NEUTROPHIL-RELEASING ACTIVITY OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR IN MYELOKATHEXIS, British Journal of Haematology, vol.270, issue.1, pp.169-170, 1992.
DOI : 10.1007/BF01026389

P. Cernelc, D. Andoljsek, U. Mlakar, J. Pretnar, M. Modic et al., Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis, Pflugers Arch, vol.440, pp.81-82, 2000.

K. Chae, J. Ertle, and M. Tharp, B-cell lymphoma in a patient with WHIM syndrome, Journal of the American Academy of Dermatology, vol.44, issue.1, pp.124-128, 2001.
DOI : 10.1067/mjd.2001.111337

M. Christ and C. Dillon, Myelokathexis in a mother and infant: a second case suggesting dominant inheritance, Mil Med, vol.162, pp.827-828, 1997.

N. Cipriani, E. Blair, and J. Taxy, WHIM syndrome and oral squamous cell carcinoma, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.109, issue.1, pp.105-108, 2010.
DOI : 10.1016/j.tripleo.2009.08.011

A. Ganser, O. Ottmann, H. Erdmann, G. Schulz, and D. Hoelzer, The Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Neutropenia and Related Morbidity in Chronic Severe Neutropenia, Annals of Internal Medicine, vol.111, issue.11
DOI : 10.7326/0003-4819-111-11-887

E. Goddard, E. Hughes, and D. Beatty, A case of immunodeficiency characterized by neutropenia, hypogammaglobulinaemia, recurrent infections and warts, Clinical & Laboratory Haematology, vol.270, issue.3, pp.297-302, 1994.
DOI : 10.1111/j.1365-2257.1994.tb00425.x

R. Gorlin, B. Gelb, G. Diaz, K. Lofsness, M. Pittelkow et al., WHIM syndrome, an autosomal dominant disorder: Clinical, hematological, and molecular studies, American Journal of Medical Genetics, vol.270, issue.5, pp.368-376, 2000.
DOI : 10.1002/(SICI)1096-8628(20000424)91:5<368::AID-AJMG10>3.0.CO;2-9

A. Gulino, D. Moratto, S. Sozzani, P. Cavadini, K. Otero et al., Altered leukocyte response to CXCL12 in patients with warts hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome, Blood, vol.104, issue.2, pp.444-452, 2004.
DOI : 10.1182/blood-2003-10-3532

J. Hagan and P. Nguyen, WHIM Syndrome, Mayo Clinic Proceedings, vol.82, issue.9, p.1031, 2007.
DOI : 10.4065/82.9.1031

A. Handisurya, C. Schellenbacher, B. Reininger, F. Koszik, P. Vyhnanek et al., A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome, Vaccine, vol.28, issue.30, pp.4837-4841, 2010.
DOI : 10.1016/j.vaccine.2010.04.057

U. Hess, A. Ganser, H. Schnurch, G. Seipelt, O. Ottmann et al., MYELOKATHEXIS TREATED WITH RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (rhGM-CSF), British Journal of Haematology, vol.80, issue.2
DOI : 10.1111/j.1365-2141.1992.tb08910.x

J. Hord, J. Whitlock, J. Gay, and J. Lukens, Clinical Features of Myelokathexis and Treatment with Hematopoietic Cytokines, Journal of Pediatric Hematology/Oncology, vol.19, issue.5, pp.443-448, 1997.
DOI : 10.1097/00043426-199709000-00007

S. Imashuku, A. Miyagawa, T. Chiyonobu, H. Ishida, T. Yoshihara et al., Epstein-Barr virus-associated T-lymphoproliferative disease with hemophagocytic syndrome, followed by fatal intestinal B lymphoma in a young adult female with WHIM syndrome, Annals of Hematology, vol.81, issue.8, pp.470-473, 2002.
DOI : 10.1007/s00277-002-0489-9

C. Krill, . Jr, H. Smith, and A. Mauer, Chronic Idiopathic Granulocytopenia, New England Journal of Medicine, vol.270, issue.19, pp.973-979, 1964.
DOI : 10.1056/NEJM196405072701902

G. Krivan, M. Erdos, K. Kallay, G. Benyo, A. Toth et al., Successful umbilical cord blood stem cell transplantation in a child with WHIM syndrome, European Journal of Haematology, vol.81, issue.3, pp.274-275, 2010.
DOI : 10.1111/j.1600-0609.2009.01368.x

D. Mcdermott, Q. Liu, U. J. Kwatemaa, N. Naya-o-'brien, S. Penzak et al., The CXCR4 antagonist plerixafor corrects panleukopenia in patients with WHIM syndrome, Blood, vol.118, issue.18, pp.4957-4962, 2011.
DOI : 10.1182/blood-2011-07-368084

W. Mentzer, . Jr, R. Johnston, . Jr, R. Baehner et al., An Unusual Form of Chronic Neutropenia in a Father and Daughter with Hypogammaglobulinaemia, British Journal of Haematology, vol.270, issue.3, pp.313-322, 1977.
DOI : 10.1111/j.1749-6632.1955.tb45983.x

O. 'regan, S. Newman, and A. , 'Myelokathexis', American Journal of Diseases of Children, vol.131, issue.6, pp.655-658, 1977.
DOI : 10.1001/archpedi.1977.02120190049011

M. Palm, S. Tyring, P. Rady, and M. Tharp, Human Papillomavirus Typing of Verrucae in a Patient With WHIM Syndrome, Archives of Dermatology, vol.146, issue.8, pp.931-932, 2010.
DOI : 10.1001/archdermatol.2010.184

A. Plebani, A. Cantu-rajnoldi, G. Collo, P. Allavena, A. Biolchini et al., Myelokathexis associated with multiple congenital malformations: Immunological study on phagocytic cells and lymphocytes, European Journal of Haematology, vol.87, issue.1, pp.12-17, 1988.
DOI : 10.1111/j.1600-0609.1988.tb00790.x

D. Sanmun, D. Garwicz, C. Smith, J. Palmblad, and B. Fadeel, Stromal-derived factor-1 abolishes constitutive apoptosis of WHIM syndrome neutrophils harbouring a truncating CXCR4 mutation, British Journal of Haematology, vol.175, issue.6, pp.640-644, 2006.
DOI : 10.1158/1078-0432.CCR-04-1850

M. Siedlar, Z. Rudzki, M. Strach, E. Trzyna, A. Pituch-noworolska et al., Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome, Archivum Immunologiae et Therapiae Experimentalis, vol.270, issue.6, pp.419-425, 2008.
DOI : 10.1007/s00005-008-0046-x

S. Taniuchi, A. Yamamoto, T. Fujiwara, M. Hasui, S. Tsuji et al., Dizygotic twin sisters with myelokathexis: Mechanism of its neutropenia, American Journal of Hematology, vol.267, issue.2, pp.106-111, 1999.
DOI : 10.1002/(SICI)1096-8652(199910)62:2<106::AID-AJH8>3.0.CO;2-D

S. Taniuchi, M. Masuda, Y. Fujii, K. Izawa, H. Kanegane et al., The role of a mutation of the CXCR4 gene in WHIM syndrome, Haematologica, vol.90, pp.1271-1272, 2005.

M. Tarzi, M. Jenner, K. Hattotuwa, A. Faruqi, G. Diaz et al., Sporadic case of warts, hypogammaglobulinemia, immunodeficiency, and myelokathexis syndrome. JA ll er g yC li n Immunol, pp.1101-1105, 2005.

L. Tassone, L. Notarangelo, V. Bonomi, G. Savoldi, A. Sensi et al., Clinical and genetic diagnosis of warts, hypogammaglobulinemia, infections, and myelokathexis syndrome in 10 patients, Journal of Allergy and Clinical Immunology, vol.123, issue.5, pp.1170-1173, 2009.
DOI : 10.1016/j.jaci.2008.12.1133

B. Weston, R. Axtell, R. Todd, . Iii, M. Vincent et al., Clinical and biologic effects of granulocyte colony stimulating factor in the treatment of myelokathexis, The Journal of Pediatrics, vol.118, issue.2, pp.229-234, 1991.
DOI : 10.1016/S0022-3476(05)80488-3

M. Wetzler, M. Talpaz, M. Kellagher, J. Gutterman, and R. Kurzrock, Myelokathexis: Normalization of Neutrophil Counts and Morphology by GM-CSF, JAMA: The Journal of the American Medical Association, vol.267, issue.16, pp.2179-2180, 1992.
DOI : 10.1001/jama.1992.03480160037015

G. Calandra, G. Bridger, and S. Fricker, CXCR4 in Clinical Hematology, Curr Top Microbiol Immunol, vol.341, pp.173-191, 2010.
DOI : 10.1007/82_2010_26

D. Dale, A. Bolyard, M. Kelley, E. Westrup, V. Makaryan et al., The CXCR4 antagonist plerixafor is a potential therapy for myelokathexis, WHIM syndrome, Blood, vol.118, issue.18, pp.4963-4966, 2011.
DOI : 10.1182/blood-2011-06-360586

J. Donadieu, O. Fenneteau, B. Beaupain, N. Mahlaoui, and C. Bellanne, Congenital neutropenia: diagnosis, molecular bases and patient management, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.26, 2011.
DOI : 10.1038/sj.ejhg.5200366

B. Beaupain, T. Leblanc, O. Reman, O. Hermine, J. Vannier et al., Is pegfilgrastim safe and effective in congenital neutropenia? An analysis of the French Severe Chronic Neutropenia registry. Pediatr Blood Cancer, pp.1068-1073, 2009.

C. Bellanne-chantelot, S. Clauin, T. Leblanc, B. Cassinat, F. Rodrigues-lima et al., Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register, Blood, vol.103, issue.11, pp.4119-4125, 2004.
DOI : 10.1182/blood-2003-10-3518

J. Donadieu, T. Leblanc, B. Bader-meunier, M. Barkaoui, O. Fenneteau et al., Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group, Haematologica, vol.90, pp.45-53, 2005.

V. Latger-cannard, D. Bensoussan, and P. Bordigoni, The WHIM syndrome shows a peculiar dysgranulopoiesis: myelokathexis, British Journal of Haematology, vol.132, issue.6, p.669, 2006.
DOI : 10.1111/j.1365-2141.2005.05908.x

H. Vinurel, N. Freymond, Y. Pacheco, and G. Devouassoux, Le syndrome de Whim??: une cause exceptionnelle de bronchiectasies diffuses, Revue des Maladies Respiratoires, vol.25, issue.5, pp.614-618, 2008.
DOI : 10.1016/S0761-8425(08)71621-8

R. Buckley, S. Dees, O. Fallon, and W. , Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy, Pediatrics, vol.41, pp.600-611, 1968.

A. Hsu, E. Sampaio, J. Khan, K. Calvo, J. Lemieux et al., Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome, Blood, vol.118, issue.10, pp.2653-2655, 2011.
DOI : 10.1182/blood-2011-05-356352

J. Kazenwadel, G. Secker, Y. Liu, J. Rosenfeld, R. Wildin et al., Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature, Blood, vol.119, issue.5, pp.1283-1291, 2012.
DOI : 10.1182/blood-2011-08-374363

G. Diaz and A. Gulino, WHIM syndrome: A defect in CXCR4 signaling, Current Allergy and Asthma Reports, vol.19, issue.5, pp.350-355, 2005.
DOI : 10.1007/s11882-005-0005-0

T. Kawai and H. Malech, WHIM syndrome: congenital immune deficiency disease, Current Opinion in Hematology, vol.16, issue.1, pp.20-26, 2009.
DOI : 10.1097/MOH.0b013e32831ac557
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2673024

D. Mcdermott, D. Ravin, S. Jun, H. Liu, Q. Priel et al., Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis, Blood, vol.116, issue.15, pp.2793-2802, 2010.
DOI : 10.1182/blood-2010-01-265942

K. Eash, A. Greenbaum, P. Gopalan, and D. Link, CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow, Journal of Clinical Investigation, vol.120, issue.7, pp.2423-2431, 2010.
DOI : 10.1172/JCI41649DS1

R. Maran, M. Mittelman, A. Cohen, and M. Djaldetti, Myelokathexis and Monocytosis in a Patient with Gastric Cancer, Acta Haematologica, vol.87, issue.4, pp.210-212, 1992.
DOI : 10.1159/000204770

G. Diaz, CXCR4 mutations in WHIM syndrome: a misguided immune system?, Immunological Reviews, vol.131, issue.1, pp.235-243, 2005.
DOI : 10.1182/blood-2002-10-3293

A. Doncker, K. Balabanian, C. Bellanne-chantelot, G. De, M. Revest et al., Two cases of disseminated Mycobacterium avium infection associated with a new immunodeficiency syndrome related to CXCR4 dysfunctions, Clinical Microbiology and Infection, vol.17, issue.2, pp.135-139, 2011.
DOI : 10.1111/j.1469-0691.2010.03187.x
URL : https://hal.archives-ouvertes.fr/inserm-00869170

P. Ostergaard, M. Simpson, F. Connell, C. Steward, G. Brice et al., Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome), Nature Genetics, vol.96, issue.10, pp.929-931, 2011.
DOI : 10.1002/dvdy.22373

H. Abdollahpour, G. Appaswamy, D. Kotlarz, J. Diestelhorst, R. Beier et al., The phenotype of human STK4 deficiency, Blood, vol.119, issue.15, pp.3450-3457, 2012.
DOI : 10.1182/blood-2011-09-378158

K. Chow, E. Brotin, K. Ben, L. Carthagena, S. Teissier et al., A Pivotal Role for CXCL12 Signaling in HPV-Mediated Transformation of Keratinocytes: Clues to??Understanding HPV-Pathogenesis in WHIM Syndrome, Cell Host & Microbe, vol.8, issue.6, pp.523-533, 2010.
DOI : 10.1016/j.chom.2010.11.006

R. Badolato, L. Dotta, L. Tassone, G. Amendola, F. Porta et al., Tetralogy of Fallot is an Uncommon Manifestation of Warts, Hypogammaglobulinemia, Infections, and Myelokathexis Syndrome, The Journal of Pediatrics, vol.161, issue.4
DOI : 10.1016/j.jpeds.2012.05.058

M. Dugan, R. Maziarz, W. Bensinger, A. Nademanee, J. Liesveld et al., Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilization, Bone Marrow Transplantation, vol.14, issue.1, pp.39-47, 2010.
DOI : 10.1038/sj.bmt.1705908

C. Hendrix, A. Collier, M. Lederman, D. Schols, R. Pollard et al., Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.37, issue.2, pp.1253-1262, 2004.
DOI : 10.1097/01.qai.0000137371.80695.ef

B. Cohen, Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry, Orphanet Journal of Rare Diseases, 20127.
URL : https://hal.archives-ouvertes.fr/inserm-00796145